97 related articles for article (PubMed ID: 2575976)
1. Clinical pharmacology of epanolol. Pharmacodynamic aspects.
Harry JD
Drugs; 1989; 38 Suppl 2():18-27. PubMed ID: 2575976
[TBL] [Abstract][Full Text] [Related]
2. The pharmacology of epanolol (ICI 141292)--a new beta 1-selective adrenoceptor partial agonist.
Bilski AJ; Hadfield SE; Wale JL
J Cardiovasc Pharmacol; 1988 Aug; 12(2):227-32. PubMed ID: 2459554
[TBL] [Abstract][Full Text] [Related]
3. Effect of partial agonist activity on the side effects of beta-blockade in patients with chronic stable angina.
Chambers J; Ong ML; Akhras F; Adam G; Jackson G
Drugs; 1989; 38 Suppl 2():39-44. PubMed ID: 2575979
[TBL] [Abstract][Full Text] [Related]
4. Epanolol. A new once-daily antianginal agent: dose finding and long term efficacy.
Akhras F; Jackson G
Drugs; 1989; 38 Suppl 2():28-34. PubMed ID: 2575977
[TBL] [Abstract][Full Text] [Related]
5. The effects of selective beta-adrenoceptor antagonists and partial agonist activity on renal function during exercise in normal subjects and those with moderate renal impairment.
Taverner D; Mackay IG; Craig K; Watson ML
Br J Clin Pharmacol; 1991 Sep; 32(3):387-91. PubMed ID: 1685667
[TBL] [Abstract][Full Text] [Related]
6. Effects of beta-adrenoceptor blockade on heart rate and physiological tremor in diabetics with autonomic neuropathy. A comparative study of epanolol, atenolol and pindolol.
Reid W; Ewing DJ; Harry JD; Smith HJ; Neilson JM; Clarke BF
Br J Clin Pharmacol; 1987 Apr; 23(4):383-9. PubMed ID: 2883987
[TBL] [Abstract][Full Text] [Related]
7. Modest antihypertensive effect of epanolol, a beta 1-selective receptor blocker with beta 1 agonist activity: an acute and long-term hemodynamic study at rest and during exercise and double crossover comparison with atenolol on ambulatory blood pressure.
Omvik P; Lund-Johansen P; Haugland H
Cardiovasc Drugs Ther; 1993 Feb; 7(1):125-32. PubMed ID: 8097925
[TBL] [Abstract][Full Text] [Related]
8. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive and hormonal responses to beta-blockade with intrinsic sympathomimetic activity: pindolol versus epanolol.
Simon G; Wittig VJ
J Cardiovasc Pharmacol; 1987 Nov; 10(5):543-7. PubMed ID: 2447403
[TBL] [Abstract][Full Text] [Related]
10. Investigation of possible pharmacokinetic and pharmacodynamic interactions between epanolol and digoxin.
Lefebvre RA; Bogaert MG; Duprez D
Eur J Clin Pharmacol; 1990; 38(5):505-7. PubMed ID: 1974206
[TBL] [Abstract][Full Text] [Related]
11. The influence of beta-adrenoceptor antagonists with and without partial agonist activity on exercise tolerance and muscle lactate production.
Lees KR; Curzio J; Farish E; Borland WW; Rubin PC
Eur J Clin Pharmacol; 1987; 33(4):415-7. PubMed ID: 2894994
[TBL] [Abstract][Full Text] [Related]
12. The effect of epanolol on intra-arterial ambulatory blood pressure and baroreceptor heart rate reflex in essential hypertension.
Smith SA; Littler WA
Clin Exp Pharmacol Physiol; 1988 Apr; 15(4):327-31. PubMed ID: 2908433
[TBL] [Abstract][Full Text] [Related]
13. Effects of a single oral administration of Epanolol on exercise tolerance in patients with stable effort angina pectoris.
Vandenbosch H; Piessens J; De Geest H
Acta Cardiol; 1991; 46(1):11-25. PubMed ID: 1674394
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of epanolol after acute and chronic oral dosing in elderly patients with stable angina pectoris.
Hosie J; Scott AK; Petrie JC; Cockshott ID
Br J Clin Pharmacol; 1990 Mar; 29(3):333-7. PubMed ID: 1968755
[TBL] [Abstract][Full Text] [Related]
15. Effects of epanolol, a selective beta1-blocker with intrinsic sympathomimetic activity, in patients with ischemic left ventricular dysfunction.
Van Den Heuvel AF; van der Ent M; van Veldhuisen DJ; Kruijssen DA; Bartels GL; Remme WJ
J Cardiovasc Pharmacol; 1998 Apr; 31(4):506-12. PubMed ID: 9554797
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of beta-adrenoceptor partial agonists on isolated rat atrium.
Vigholt-Sørensen E; Påby L; Halliday SE; Snow HM
Pharmacol Toxicol; 1991 Nov; 69(5):351-4. PubMed ID: 1687080
[TBL] [Abstract][Full Text] [Related]
17. Intrinsic sympathomimetic activity of cardioselective beta-adrenoceptor blockers and effects on renal function.
Mackay IG; Macnicol AM; Smith HJ; Cumming AD; Watson ML
Br J Clin Pharmacol; 1985 Sep; 20(3):197-203. PubMed ID: 2864052
[TBL] [Abstract][Full Text] [Related]
18. Effects of epanolol and metoprolol on the heart measured by 24-hour holter monitoring.
Withagen AJ; Corbeij HM; Huige MC; Kragten JA; Vermeulen A
Drugs; 1989; 38 Suppl 2():67-9. PubMed ID: 2575985
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of epanolol (ICI 141,292) in healthy young volunteers and comparative data in elderly patients with angina and subjects with renal or hepatic impairment.
Cockshott ID
Drugs; 1989; 38 Suppl 2():10-7. PubMed ID: 2575975
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of epanolol versus metoprolol in angina pectoris: report from a Swedish multicentre study of exercise tolerance.
Rydén L
J Intern Med; 1992 Jan; 231(1):7-11. PubMed ID: 1346268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
